{"id":"https://openalex.org/W4285010296","doi":"https://doi.org/10.1111/ajd.13893","title":"Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study","display_name":"Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-11","ids":{"openalex":"https://openalex.org/W4285010296","doi":"https://doi.org/10.1111/ajd.13893","pmid":"https://pubmed.ncbi.nlm.nih.gov/35816576","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9542143"},"language":"en","primary_location":{"id":"doi:10.1111/ajd.13893","doi":"https://doi.org/10.1111/ajd.13893","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ajd.13893","pdf_url":null,"source":{"id":"https://openalex.org/S140888521","display_name":"Australasian Journal of Dermatology","issn_l":"0004-8380","issn":["0004-8380","0365-3609","1440-0960"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australasian Journal of Dermatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4285010296"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1111/ajd.13893","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000398504","display_name":"Peter Anthony Foley","orcid":"https://orcid.org/0000-0001-5891-5607","observed_orcids":["https://orcid.org/0000-0001-5891-5607"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I4210087110","display_name":"St Vincent's Hospital Melbourne","ror":"https://ror.org/001kjn539","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087110","https://openalex.org/I4210098850"]},{"id":"https://openalex.org/I4210165890","display_name":"Skin Health Institute","ror":"https://ror.org/05x56xv16","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210165890"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Peter Foley","raw_affiliation_strings":["Skin Health Institute Inc., Carlton, Victoria, Australia","St Vincent's Department of Medicine (Dermatology), St Vincent's Hospital Melbourne, The University of Melbourne, Fitzroy, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skin Health Institute Inc., Carlton, Victoria, Australia","institution_ids":["https://openalex.org/I4210165890"]},{"raw_affiliation_string":"St Vincent's Department of Medicine (Dermatology), St Vincent's Hospital Melbourne, The University of Melbourne, Fitzroy, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I4210087110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019091788","display_name":"Lynda J. Spelman","orcid":"https://orcid.org/0000-0002-7330-4713","observed_orcids":["https://orcid.org/0000-0002-7330-4713"]},"institutions":[{"id":"https://openalex.org/I4210147790","display_name":"Veracity Clinical Research","ror":"https://ror.org/04eba0590","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210147790"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Lynda Spelman","raw_affiliation_strings":["Veracity Clinical Research Pty. Ltd., Woolloongabba, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veracity Clinical Research Pty. Ltd., Woolloongabba, Queensland, Australia","institution_ids":["https://openalex.org/I4210147790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000758369","display_name":"Dedee Frances Murrell","orcid":"https://orcid.org/0000-0003-2971-0199","observed_orcids":["https://orcid.org/0000-0003-2971-0199"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Dedee F. Murrell","raw_affiliation_strings":["Department of Dermatology, University of New South Wales, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of New South Wales, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078244239","display_name":"Eric Mate","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Mate","raw_affiliation_strings":["Novartis Pharmaceuticals, Australia Pty. Ltd., Macquarie Park, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Australia Pty. Ltd., Macquarie Park, New South Wales, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081562584","display_name":"Rebecca Tronnberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Tronnberg","raw_affiliation_strings":["Novartis Pharmaceuticals, Australia Pty. Ltd., Macquarie Park, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Australia Pty. Ltd., Macquarie Park, New South Wales, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087214355","display_name":"Patricia Margaret Lowe","orcid":"https://orcid.org/0000-0002-7862-7060","observed_orcids":["https://orcid.org/0000-0002-7862-7060"]},"institutions":[{"id":"https://openalex.org/I2799732068","display_name":"Royal Prince Alfred Hospital","ror":"https://ror.org/05gpvde20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799732068"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Patricia M. Lowe","raw_affiliation_strings":["Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia","institution_ids":["https://openalex.org/I2799732068"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5000398504"],"corresponding_institution_ids":["https://openalex.org/I165779595","https://openalex.org/I4210087110","https://openalex.org/I4210165890"],"apc_list":{"value":3700,"currency":"USD","value_usd":3700},"apc_paid":{"value":3700,"currency":"USD","value_usd":3700},"fwci":0.6326,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.57345737,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"63","issue":"3","first_page":"312","last_page":"320"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.890999972820282},{"id":"https://openalex.org/keywords/non-interventional-study","display_name":"non-interventional study","score":0.7360000014305115},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6179999709129333},{"id":"https://openalex.org/keywords/dermatology-life-quality-index","display_name":"Dermatology Life Quality Index","score":0.7720000147819519},{"id":"https://openalex.org/keywords/aqol-8d","display_name":"AQoL-8D","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pasi-response","display_name":"PASI response","score":0.7590000033378601},{"id":"https://openalex.org/keywords/il-23-inhibition","display_name":"IL-23 inhibition","score":0.6769999861717224},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.75},{"id":"https://openalex.org/keywords/australian-patients","display_name":"Australian patients","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.9822819232940674},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9586188793182373},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.9156707525253296},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.7592815160751343},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7519316673278809},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.7262257933616638},{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.6553038954734802},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47016164660453796},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.42248159646987915},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3486393094062805},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.25099971890449524},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.12853100895881653},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/ajd.13893","doi":"https://doi.org/10.1111/ajd.13893","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ajd.13893","pdf_url":null,"source":{"id":"https://openalex.org/S140888521","display_name":"Australasian Journal of Dermatology","issn_l":"0004-8380","issn":["0004-8380","0365-3609","1440-0960"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australasian Journal of Dermatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9542143","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9542143/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9542143/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australas J Dermatol","raw_type":"Text"},{"id":"pmid:35816576","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35816576","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Australasian journal of dermatology","raw_type":"Journal Article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/335759","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/335759","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/ajd.13893","doi":"https://doi.org/10.1111/ajd.13893","is_oa":true,"landing_page_url":"https://doi.org/10.1111/ajd.13893","pdf_url":null,"source":{"id":"https://openalex.org/S140888521","display_name":"Australasian Journal of Dermatology","issn_l":"0004-8380","issn":["0004-8380","0365-3609","1440-0960"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australasian Journal of Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G8490170426","display_name":null,"funder_award_id":"http://www.ismpp.org/gpp3","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"}],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320314709","display_name":"Dermira","ror":"https://ror.org/02ac14420"},{"id":"https://openalex.org/F4320318070","display_name":"Amryt Pharma","ror":"https://ror.org/02nph9e73"},{"id":"https://openalex.org/F4320318412","display_name":"Argenx","ror":"https://ror.org/04spfxf63"},{"id":"https://openalex.org/F4320320974","display_name":"University of Melbourne","ror":"https://ror.org/01ej9dk98"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320325987","display_name":"Galderma","ror":"https://ror.org/05fswdm20"},{"id":"https://openalex.org/F4320328070","display_name":"Sun Pharma","ror":"https://ror.org/04vnqkx80"},{"id":"https://openalex.org/F4320332071","display_name":"LEO Pharma","ror":"https://ror.org/05tzrdd39"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320334531","display_name":"Novartis Australia","ror":"https://ror.org/01w8m1867"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4285010296.pdf","grobid_xml":"https://content.openalex.org/works/W4285010296.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1935617463","https://openalex.org/W1973354423","https://openalex.org/W1987209737","https://openalex.org/W1996308907","https://openalex.org/W2019808731","https://openalex.org/W2021018799","https://openalex.org/W2080165152","https://openalex.org/W2097896724","https://openalex.org/W2116956799","https://openalex.org/W2339525054","https://openalex.org/W2407298765","https://openalex.org/W2521243079","https://openalex.org/W2734398306","https://openalex.org/W2766460886","https://openalex.org/W2792493694","https://openalex.org/W2792921896","https://openalex.org/W2884955984","https://openalex.org/W2888975094","https://openalex.org/W2896987528","https://openalex.org/W2901667064","https://openalex.org/W2906944548","https://openalex.org/W2963061918","https://openalex.org/W2973523138","https://openalex.org/W2996963829","https://openalex.org/W3009233694","https://openalex.org/W3009872190","https://openalex.org/W3022612060","https://openalex.org/W3027582128","https://openalex.org/W3093227824","https://openalex.org/W4256153315"],"related_works":["https://openalex.org/W4283333130","https://openalex.org/W2808235621","https://openalex.org/W2281983923","https://openalex.org/W7165689509","https://openalex.org/W2905662485","https://openalex.org/W3027582128","https://openalex.org/W7167415055","https://openalex.org/W3110358001","https://openalex.org/W2954778191","https://openalex.org/W4388814953"],"abstract_inverted_index":{"BACKGROUND:":[0],"Psoriasis":[1,87],"imposes":[2],"a":[3,9,48,137,153,224],"disease":[4],"burden":[5],"that":[6,35],"can":[7],"have":[8],"profound":[10],"negative":[11],"impact":[12],"on":[13],"patients'":[14,183,228],"quality":[15],"of":[16,81,144,157,188,209],"life":[17],"(QoL).":[18],"HOPE":[19,46,232],"was":[20,47,130,146,211],"the":[21,68,73,120,231,234,246],"first":[22,235],"non-interventional":[23],"study":[24,55,66,237],"conducted":[25],"in":[26,33,39,56,63,70,96,124,140,182,227,230,238,245],"patients":[27,57,189,239],"with":[28,43,58,100,152,198,213,240],"severe":[29,59,241],"chronic":[30,60,242],"plaque":[31,61,243],"psoriasis":[32,62,244],"Australia":[34],"evaluated":[36],"health-related":[37],"QoL":[38,229],"response":[40,97],"to":[41,98,149,175,202],"treatment":[42,99,222],"secukinumab.":[44],"METHODS:":[45],"prospective,":[49],"open-label,":[50],"single-arm,":[51],"multicentre,":[52],"non-interventional,":[53],"exploratory":[54],"Australia.":[64],"The":[65,159,206],"investigated":[67],"change":[69,156,162],"QoL,":[71],"using":[72],"Dermatology":[74],"Life":[75],"Quality":[76,80],"Index":[77,91],"(DLQI),":[78],"Assessment":[79],"Life-8":[82],"Dimension":[83],"questionnaire":[84],"(AQoL-8D)":[85],"and":[86,89,93],"Area":[88],"Severity":[90],"(PASI),":[92],"safety":[94,207,218],"profile":[95,208],"secukinumab":[101,210],"300":[102],"mg":[103],"SC":[104],"weekly":[105],"for":[106,113,165],"4":[107],"weeks":[108],"followed":[109],"by":[110],"monthly":[111],"maintenance":[112],"58":[114,177],"weeks.":[115],"RESULTS:":[116],"At":[117],"Week":[118,150,172,176,195,203],"14,":[119],"mean":[121,154,160],"percentage":[122,155,161],"reduction":[123],"total":[125,168],"DLQI":[126],"score":[127,169],"from":[128,163,171],"baseline":[129,164],"-82.4%":[131],"(n":[132],"=":[133],"65),":[134],"which":[135],"indicates":[136],"substantial":[138],"improvement":[139,145,181,226],"QoL.":[141,184],"This":[142],"level":[143],"sustained":[147,200],"up":[148,201],"\u226558,":[151],"-87.4%.":[158],"AQoL-8D":[166],"weighted":[167],"decreased":[170],"14":[173,196],"(41.1%)":[174],"(35.2%),":[178],"indicating":[179],"an":[180],"A":[185],"high":[186],"proportion":[187],"achieved":[190],"PASI":[191],"75/90/100":[192],"responses":[193],"at":[194],"(97.0%/71.2%/34.8%),":[197],"rates":[199],"\u226558":[204],"(100%/87.9%/43.1%).":[205],"favourable,":[212],"no":[214],"cumulative":[215],"or":[216],"unexpected":[217],"concerns.":[219],"CONCLUSION:":[220],"Secukinumab":[221],"demonstrated":[223],"striking":[225],"study,":[233],"real-world":[236],"Australian":[247],"clinical":[248],"setting.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4285010296","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2022-07-12T00:00:00"}
